 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summary
Celgene
CELG
Release date: April 25, 2019
for quarter ending: March 31, 2019 (first quarter, Q1)
Overview: To be acquired by Bristol-Myers Squibb (BMY). Strong revenue growth. Did not have a Q1 analyst conference. Did put out a Celgene Q1 2019 Results Press Release and the quarter's SEC filing.
OpenIcon Analyst Conference Summaries Main Page
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMGN |
| BIIB |
| CLDX |
| CELG |
| EPZM |
| GILD |
| GLYC |
| INO |
| ISRG |
| MCHP |
| MYL. |
| PLX |
| REGN |
| SGEN | TTPH |
| VBLT |
| VSTM |
| XLNX |
| XLRN |
Disclaimer: My analyst summaries may include both our condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. Summaries, of necessity, eliminate fine-grains. These notes are for my own use, but I am sharing them with the investment community. See my Seeking Alpha articles for my opinions.
Copyright 2019 William P. Meyers